Lynn Bartko

Cleveland Clinic FoundationCleveland, Ohio - 44195 (216-445-8454) |
- CLINICAL TRIALS 1
- CONDITIONS1
- INTERVENTIONS1
- SINCE2009

A Study of Ranibizumab Administered Monthly or on an As-Needed Basis in Patients With Subfoveal Neovascular Age-Related Macular Degeneration
April 2009 - August 2013
Macular Degeneration
Ranibizumab



